Avanafil: a review of its use in patients with erectile dysfunction (Q34655442)

3 August 2017

title

Avanafil: a review of its use in patients with erectile dysfunction (English)

1 reference

3 August 2017

Mark Sanford

1 reference

3 August 2017

language of work or name

1 reference

1 October 2013

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

853-862

1 reference

An overview of the diagnosis and treatment of erectile dysfunction.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

New treatment options for erectile dysfunction in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

1481 A RANDOMIZED, PLACEBO CONTROLLED, DOUBLE BLIND, MULTICENTER THERAPEUTIC EXPLORATORY CLINICAL STUDY FOR THE EVALUATION OF THE EFFICACY AND SAFETY OF AVANAFIL IN THE PATIENTS WITH ERECTILE DYSFUNCTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0112-X

A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23955441

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23955441

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23955441

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40266-013-0112-X

1 reference

3 August 2017

1 reference